Current Naming Opportunities

CHAIRS STILL TO BE NAMED GOAL
Prevention Chair
Current Program Chair: James R. Marshall, PhD

$1.5 M

Developments at RPCI and worldwide during the past decade have generated an unprecedented level of confidence that many more cancers can be prevented and controlled before they require intensive treatments. Investment in the Department of Cancer Prevention and Population Sciences will provide seed funding for…
  • Collaborative lab research and population studies of nutritional, environmental (e.g. smoking) and chemical risks for cancer.
  • Intervention studies (chemoprevention, molecular epidemiology, etc.) to identify new strategies for detecting and treating precancerous conditions and cancers at earlier, more treatable stages.
  • Large databanks of patient biological samples and lifestyle information to enable scientists to more readily initiate promising studies.

Surgery Chair
Current Program Chair: To Be Assigned

$1.5 M

The future of surgical procedures is underway at Roswell Park, with the goal of achieving maximum remission rates with smaller incisions and quicker recovery times. Roswell Park is quickly emerging as a leader in the world of minimally-invasive surgery, and the Endowed Chairholder will manage strategies including…
  • Clinical study and expansion of the use of robotic-assisted surgery, and developing new technologies to improve robotic-assisted surgical systems.
  • Exploring and perfecting additional laparoscopic or “keyhole” surgical options.
  • Expansion of the use of radiofrequency ablation, computer-assisted “stereotactic” surgery and microsurgeries.
PROFESSORSHIPS STILL TO BE NAMED GOAL
Radiation Medicine Professorship
To Be Assigned

$750 K

Investigating and utilizing the newest approaches for the delivery of radiation to patients in order to treat the cancer, and not healthy tissue, is a primary goal of Radiation Medicine. Leading-edge patient care and research funded through your investment in this area includes…
  • Gamma Knife radiosurgery—excising brain lesions without skull penetration—and pursuing new Gamma Knife applications for other cancers.
  • Dosimetry, computer-mapping and image-guided radiation therapy.
  • Research of microscopic “nanodevices” to deliver finely-targeted radiation and drug therapies to cells.

Pharmacology Professorship
To Be Assigned

$750 K

Accelerating the bench-to-bedside development of new drugs to treat cancer is at the forefront of RPCI’s research endeavors. An aggressive and multidisciplinary research program is underway to capitalize on the latest advances in cancer genetics and molecular biology. Pharmacology research includes…
  • Creating new understanding of the cellular and genetic regulatory events involved in cancer cell growth and cell death.
  • Validating new anticancer targets such as specific genes, key enzymes and related proteins.
  • Developing novel drugs through RPCI’s new Clinical Research Center, and exploring the innovative use of naturally occurring compounds (e.g. vitamin D derivatives, selenium, fatty acids, etc.) to fight cancer.

Molecular Imaging Professorship
To Be Assigned

$750 K

Just as technological advances have spawned an explosion of knowledge in cancer research, prevention and surgery, equally dramatic advances in physics, engineering and chemistry are bringing forth novel ways to more accurately diagnosis cancer and monitor treatment. This professorship will lead areas including…
  • Pursuing emerging imaging techniques such as the use of chemical “spies”—radioactively labeled drugs and light-emitting molecular probes—to view changes within molecules.
  • Helping to accelerate drug discovery and testing processes by measuring the immediate cellular responses to drugs, rather than clinical effects.